Kelsey Elizabeth Gelhaus, MD | |
5200 Fairview Blvd, Wyoming, MN 55092-8013 | |
(651) 982-7000 | |
Not Available |
Full Name | Kelsey Elizabeth Gelhaus |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 10 Years |
Location | 5200 Fairview Blvd, Wyoming, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235559659 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 63545 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Fairview Lakes Health Services | Wyoming, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Fairview Clinics | 7113830142 | 658 |
News Archive
Over the past 35 years the proportion of foodborne outbreaks linked to the consumption of leafy green vegetables has substantially increased and that increase can not be completely attributed to Americans eating more salads according to research presented today (March 17) at the 2008 International Conference on Emerging Infectious Diseases in Atlanta, Georgia.
Macro Consultants LLC and Cornerstone Program Advisors LLC announce the combination of their service offerings in a partnership geared toward better serving healthcare institutions. This partnership will allow healthcare organizations which are undertaking capital projects and other improvements to benefit from a suite of project management services never before combined into a single offering.
Infection with the gastric bacterium Helicobacter pylori provides reliable protection against allergy-induced asthma, immunologists from the University of Zurich have demonstrated in an animal model together with allergy specialists from the University Medical Center of the Johannes Gutenberg University Mainz.
Inspirion Delivery Technologies, LLC ("IDT") announced today that last week the Company completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to determine the clinical and regulatory pathway to advance its abuse deterrent, extended release formulation of oxycodone.
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
› Verified 9 days ago
Entity Name | Park Nicollet Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
Over the past 35 years the proportion of foodborne outbreaks linked to the consumption of leafy green vegetables has substantially increased and that increase can not be completely attributed to Americans eating more salads according to research presented today (March 17) at the 2008 International Conference on Emerging Infectious Diseases in Atlanta, Georgia.
Macro Consultants LLC and Cornerstone Program Advisors LLC announce the combination of their service offerings in a partnership geared toward better serving healthcare institutions. This partnership will allow healthcare organizations which are undertaking capital projects and other improvements to benefit from a suite of project management services never before combined into a single offering.
Infection with the gastric bacterium Helicobacter pylori provides reliable protection against allergy-induced asthma, immunologists from the University of Zurich have demonstrated in an animal model together with allergy specialists from the University Medical Center of the Johannes Gutenberg University Mainz.
Inspirion Delivery Technologies, LLC ("IDT") announced today that last week the Company completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to determine the clinical and regulatory pathway to advance its abuse deterrent, extended release formulation of oxycodone.
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
› Verified 9 days ago
Entity Name | Fairview Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
Over the past 35 years the proportion of foodborne outbreaks linked to the consumption of leafy green vegetables has substantially increased and that increase can not be completely attributed to Americans eating more salads according to research presented today (March 17) at the 2008 International Conference on Emerging Infectious Diseases in Atlanta, Georgia.
Macro Consultants LLC and Cornerstone Program Advisors LLC announce the combination of their service offerings in a partnership geared toward better serving healthcare institutions. This partnership will allow healthcare organizations which are undertaking capital projects and other improvements to benefit from a suite of project management services never before combined into a single offering.
Infection with the gastric bacterium Helicobacter pylori provides reliable protection against allergy-induced asthma, immunologists from the University of Zurich have demonstrated in an animal model together with allergy specialists from the University Medical Center of the Johannes Gutenberg University Mainz.
Inspirion Delivery Technologies, LLC ("IDT") announced today that last week the Company completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to determine the clinical and regulatory pathway to advance its abuse deterrent, extended release formulation of oxycodone.
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
› Verified 9 days ago
Entity Name | Fairview Clinics |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
Over the past 35 years the proportion of foodborne outbreaks linked to the consumption of leafy green vegetables has substantially increased and that increase can not be completely attributed to Americans eating more salads according to research presented today (March 17) at the 2008 International Conference on Emerging Infectious Diseases in Atlanta, Georgia.
Macro Consultants LLC and Cornerstone Program Advisors LLC announce the combination of their service offerings in a partnership geared toward better serving healthcare institutions. This partnership will allow healthcare organizations which are undertaking capital projects and other improvements to benefit from a suite of project management services never before combined into a single offering.
Infection with the gastric bacterium Helicobacter pylori provides reliable protection against allergy-induced asthma, immunologists from the University of Zurich have demonstrated in an animal model together with allergy specialists from the University Medical Center of the Johannes Gutenberg University Mainz.
Inspirion Delivery Technologies, LLC ("IDT") announced today that last week the Company completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to determine the clinical and regulatory pathway to advance its abuse deterrent, extended release formulation of oxycodone.
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
› Verified 9 days ago
Entity Name | Astera Health |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134305162 PECOS PAC ID: 2961395272 Enrollment ID: O20040202001082 |
News Archive
Over the past 35 years the proportion of foodborne outbreaks linked to the consumption of leafy green vegetables has substantially increased and that increase can not be completely attributed to Americans eating more salads according to research presented today (March 17) at the 2008 International Conference on Emerging Infectious Diseases in Atlanta, Georgia.
Macro Consultants LLC and Cornerstone Program Advisors LLC announce the combination of their service offerings in a partnership geared toward better serving healthcare institutions. This partnership will allow healthcare organizations which are undertaking capital projects and other improvements to benefit from a suite of project management services never before combined into a single offering.
Infection with the gastric bacterium Helicobacter pylori provides reliable protection against allergy-induced asthma, immunologists from the University of Zurich have demonstrated in an animal model together with allergy specialists from the University Medical Center of the Johannes Gutenberg University Mainz.
Inspirion Delivery Technologies, LLC ("IDT") announced today that last week the Company completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to determine the clinical and regulatory pathway to advance its abuse deterrent, extended release formulation of oxycodone.
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
› Verified 9 days ago
Entity Name | Astera Health |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1477545333 PECOS PAC ID: 2961395272 Enrollment ID: O20060504000722 |
News Archive
Over the past 35 years the proportion of foodborne outbreaks linked to the consumption of leafy green vegetables has substantially increased and that increase can not be completely attributed to Americans eating more salads according to research presented today (March 17) at the 2008 International Conference on Emerging Infectious Diseases in Atlanta, Georgia.
Macro Consultants LLC and Cornerstone Program Advisors LLC announce the combination of their service offerings in a partnership geared toward better serving healthcare institutions. This partnership will allow healthcare organizations which are undertaking capital projects and other improvements to benefit from a suite of project management services never before combined into a single offering.
Infection with the gastric bacterium Helicobacter pylori provides reliable protection against allergy-induced asthma, immunologists from the University of Zurich have demonstrated in an animal model together with allergy specialists from the University Medical Center of the Johannes Gutenberg University Mainz.
Inspirion Delivery Technologies, LLC ("IDT") announced today that last week the Company completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to determine the clinical and regulatory pathway to advance its abuse deterrent, extended release formulation of oxycodone.
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Kelsey Elizabeth Gelhaus, MD 5200 Fairview Blvd, Wyoming, MN 55092-8013 Ph: (651) 982-7000 | Kelsey Elizabeth Gelhaus, MD 5200 Fairview Blvd, Wyoming, MN 55092-8013 Ph: (651) 982-7000 |
News Archive
Over the past 35 years the proportion of foodborne outbreaks linked to the consumption of leafy green vegetables has substantially increased and that increase can not be completely attributed to Americans eating more salads according to research presented today (March 17) at the 2008 International Conference on Emerging Infectious Diseases in Atlanta, Georgia.
Macro Consultants LLC and Cornerstone Program Advisors LLC announce the combination of their service offerings in a partnership geared toward better serving healthcare institutions. This partnership will allow healthcare organizations which are undertaking capital projects and other improvements to benefit from a suite of project management services never before combined into a single offering.
Infection with the gastric bacterium Helicobacter pylori provides reliable protection against allergy-induced asthma, immunologists from the University of Zurich have demonstrated in an animal model together with allergy specialists from the University Medical Center of the Johannes Gutenberg University Mainz.
Inspirion Delivery Technologies, LLC ("IDT") announced today that last week the Company completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to determine the clinical and regulatory pathway to advance its abuse deterrent, extended release formulation of oxycodone.
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
› Verified 9 days ago
Chen Chen, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7000 | |
Maureen Ayers Looby, M.D., M.P.H. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5200 Fairview Blvd, Ob/gyn Clinic, Wyoming, MN 55092 Phone: 651-982-7670 Fax: 651-982-7675 | |
Dr. Kaitlin Barabash, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7000 | |
Matthew William Anderson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7670 | |
Dr. Allison Ann Honke-karun, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7000 Fax: 715-483-0507 | |
Sondra S Mericle, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7670 |